
Meet Asia's Three Most Generous Philanthropists
Opinions expressed by Entrepreneur contributors are their own.
You're reading Entrepreneur Asia Pacific, an international franchise of Entrepreneur Media.
The rapid transformation of Asia's wealth map has become a subject of worldwide attention, evidenced by the growing number of regional tycoons claiming spots on the Forbes list of the world's billionaires. These are Asian entrepreneurs from India, Greater China and Central Asia, many of whom are not only business moguls but also philanthropists whose contributions are having a significant impact on society.
Coming from a region with its own specific problems, ultrawealthy Asians engage in philanthropic activities that have two defining features. On the one hand, they make donations strategically and on a large scale, following the leadership example provided by Bill Gates, the co-founder of Microsoft. Gates has been addressing some of the world's most pressing challenges, problems that markets and governments have been unable to solve on their own. On the other hand, these Asian philanthropists concentrate on their own region, where they show greater flexibility and strategic focus than local governments in identifying areas that need financial and intellectual support.
If we were to look at the world's most populous country, India, then the name Azim Premji would stand out among other philanthropists. Premji has endowed his namesake foundation, established nearly 25 years ago, with over $29 billion in Wipro shares, solidifying his commitment to social impact. The foundation operates through field offices and teacher learning centers, directly training educators and rural childcare workers. Its programs have already reached over 8 million children, improving access and quality in primary education. Beyond grassroots work, the foundation also influences systemic change by advising on national curriculum development and education policy. In 2023-2024 alone, it distributed $109 million in grants to 940 organizations working in education, health and other related sectors.
While Premji is competing with other Indian philanthropists – among them Shiv Nadar (founder of HCL Technologies) and Mukesh Ambani (chairman and managing director of Reliance Industries) – to be seen as the country's most generous giver, the region of Central Asia offers a unique example of strategic philanthropy, represented by Alisher Usmanov.
In 2021, The Sunday Times named Usmanov the most generous participant in the 20-year history of its Giving List. In total, Usmanov's charitable donations have been estimated at nearly $7.3 billion and have reached more than 60 countries around the world. His international philanthropic efforts have consistently focused on supporting the arts, education and healthcare.
In an interview with Bloomberg, he defined his attitude to philanthropy as follows: "I always thought that one should do all that one can. It may happen that I won't leave any heritage at all, but I would prefer to do everything I can to make this world better myself and right now, rather than someone else doing it after me as I don't know whether he will do it better than me."
In recent years, Usmanov has invested heavily in charitable projects in Uzbekistan, supporting rural development, education and Muslim cultural initiatives, with a focus on addressing local issues within his region. He provided assistance to tens of thousands of families in Uzbekistan and Kazakhstan who lost their homes in flooding caused by a dam bursting. He also made a significant contribution to the fight against the COVID pandemic, donating to support health workers, purchase vaccines, and build medical facilities for his fellow countrymen.
Turning to another densely populated region of Asia, we arrive in Greater China – specifically, Hong Kong. Li Ka-shing is one of the most influential business figures in the city, where he has built a vast empire across industries such as shipping, retail, telecommunications and real estate. He ranks among the world's top 10 philanthropists with lifetime donations exceeding $3.8 billion, primarily directed toward education and healthcare initiatives. Although he retired as chairman of CK Hutchison Holdings and CK Asset Holdings in 2018, he continues to serve as a senior adviser, maintaining a guiding role in the companies he established. His philanthropic efforts, led by the Li Ka Shing Foundation, focus on education and medical research primarily in Hong Kong and mainland China.
Philanthropists donate in various ways. Some prefer non-cash donations, like Azim Premji, who gave shares of his company to his charity foundation. However, this approach requires more complex management due to volatility and conversion issues. Others, like Alisher Usmanov and Li Ka-shing, opt for cash, which is simpler, more transparent, and provides immediate funding that nonprofits can use for urgent needs or ongoing programs.
No matter which form their donations take, these three prominent philanthropists, along with many other Asian business leaders, are striving to prove that true leadership isn't just about wealth; it's about redefining what impactful leadership means, where a global-through-local approach fosters a more equitable world.
With their systematic donations to education, culture and other critical social causes, these philanthropists are creating powerful synergies where private giving amplifies state-driven development efforts. This strategic focus helps to build communities where inclusive growth and cultural resilience can thrive, reshaping the future of Asia.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Bloomberg
8 minutes ago
- Bloomberg
Unilever India's New CEO Has to Invigorate a Sluggish Consumer Giant
Hindustan Unilever Ltd. 's new Chief Executive Officer Priya Nair is inheriting India's largest consumer goods maker that has seen stuttering growth in the last few years. While the Indian unit of Unilever Plc posted a forecast-beating quarterly profit last week, Nair, who took over the CEO role on Aug. 1, has her task cut out in sustaining this momentum.
Yahoo
36 minutes ago
- Yahoo
Hilary Weston, fashion mogul and former Ontario lieutenant-governor, dead at 83
Hilary Weston, an Irish-Canadian fashion mogul and former lieutenant-governor of Ontario who devoted time to issues tied to women, volunteerism and youth, has died at 83. In a statement Sunday, her family said the philanthropist and writer was shaped by an "enduring generosity and a deep commitment to helping others." "Our mother lived with unwavering devotion to her family and a belief in the power and importance of community and service," said Galen Weston Jr., who is her son and chairman and former president of Loblaw Companies Ltd. "Brilliant, brave, companionate, and beautiful, she brought a touch of magic to everything she did — in her decades of public service, philanthropy and her remarkable business career. Her greatest joy was the life she created for her family and friends — filled with warmth, love and fun." Born in Ireland on Jan. 12, 1942, Weston was the eldest of five children. She spent her early years as a fashion model to support her widowed mother and younger siblings. She married W. Galen Weston, known as Galen Weston Sr., in 1966 and moved to Toronto in the 1970s. She spent 10 years, beginning in 1986, working with luxury clothing brands Holt Renfrew and Brown Thomas & Co., as well as department store company Selfridges Group. Her charitable works include the Weston Family Foundation and the Hilary and Galen Weston Foundation following her husband's death in April 2021 at the age of 80. They were married for 55 years. Known for their connection to the Loblaw grocery store chain, the Westons are one of Canada's wealthiest families. She also co-authored two books on homes and gardens. In 1997, Weston became Ontario's lieutenant-governor and held the role until 2002, during which time she looked to highlight the contributions of volunteers, women and youth. She was given the Order of Canada in 2003 for outstanding achievement, dedication to community and service. At the time, she was the second woman to receive the award. In the family's statement, daughter Alannah Weston Cochrane said her mother loved a challenge. She also said Weston had elegance and high standards that "were matched by her warmth and sense of humour." "But it was her vision, coupled with her enormous capacity for hard work, that made her a great female leader," she said. "Her insight, wisdom and strength as well as her belief in individuals made almost anything possible." Irish Deputy Prime Minister Simon Harris said in a statement he was "deeply saddened" by Weston's death. "Hilary was a very proud Irish-Canadian who served both Ireland and Canada with distinction and generosity," he said. "She made a lasting contribution to Irish-Canadian relations. "I extend sincere condolences to her children, Alannah and Galen, and the entire Weston family." This report by The Canadian Press was first published Aug. 3, 2025. Aaron Sousa, The Canadian Press Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
36 minutes ago
- Yahoo
Alveolus Bio Secures Strategic Investment from Shilpa Medicare to Advance Groundbreaking Pulmonary Therapeutics
Shilpa Medicare Serves as Lead Investor, Positioning Alveolus Bio for Phase 2 Clinical Trials and First-in-Human Studies CAMBRIDGE, Mass. and BIRMINGHAM, Ala. and RAICHUR, India, Aug. 4, 2025 /PRNewswire/ -- Alveolus Bio, a pioneering respiratory drug development biotech company founded by Dr. Vivek Lal from University of Alabama at Birmingham, AL, has announced a strategic financing round led by Shilpa Medicare Limited (BSE: 524742) (NSE: SHILPAMED), a prominent global pharmaceutical company with extensive expertise in respiratory therapeutics manufacturing and biotechnology innovation. Through this collaboration, Shilpa Biologics, the biologics arm of Shilpa Medicare, will become Alveolus Bio's exclusive global development and manufacturing partner. This partnership propels Alveolus Bio's live biotherapeutics and small molecule platform towards Phase 2 and first-in-human clinical trials, with a lead asset for COPD progressing rapidly. Shilpa Medicare brings deep experience in drug discovery, development, and manufacturing, along with strong regulatory capabilities. Their investment and strategic involvement will accelerate the clinical advancement of Alveolus Bio's resMIT (respiratory microbiota-based inhaled therapeutics) platform. This novel platform enables targeted delivery of inhaled therapies to deep lung regions, addressing unmet needs in diseases such as COPD, Bronchopulmonary Dysplasia (BPD), and Pulmonary Fibrosis. "Securing Shilpa as our lead investor is a transformative step," said Gaurav Mehta, CEO of Alveolus Bio. "Their global pharmaceutical leadership aligns perfectly with our vision to redefine how lung diseases are treated." "Alveolus Bio's breakthrough science is poised to transform respiratory care. Through this strategic partnership with Shilpa, we combine disruptive biotech innovation with world-class commercialization, bringing life-changing therapies faster to the market," said Dr. C. Vivek Lal, Founder and CSO, Alveolus Bio. "Shilpa has always focused on enabling breakthrough biologics," said Vishnukant Bhutada, Managing Director, Shilpa Medicare. "This partnership strengthens our innovation pipeline and reinforces our role as a trusted global partner for biotech development." The financing round remains open to other strategic investors who share Alveolus Bio's vision of transforming respiratory medicine. About Shilpa MedicareShilpa Medicare is a global pharmaceutical company with capabilities across drug discovery to commercialization, specializing in respiratory therapeutics and biotech innovation. Visit About Alveolus BioA Biostack Ventures company, Alveolus Bio is developing first-in-class therapies for lung diseases using its proprietary resMIT platform. Its pipeline includes programs for COPD, BPD, Pulmonary Fibrosis, Cystic Fibrosis, and more. View original content: SOURCE Shilpa Medicare Limited Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data